QA: Xeris Biopharma Holdings Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001867096_2026_Xeris_Biopharma_Holdings_Inc.pdf

Logs

Graph

Absolute values for 0001867096, Xeris Biopharma Holdings Inc

  xvar xval
0 AssetsCurrent 240,313,000
1 IntangibleAssetsNetIncludingGoodwill 110,937,000
2 PropertyPlantAndEquipmentNet 4,945,000
3 remainder_Assets 27,332,000
4 LiabilitiesCurrent 109,574,000
5 LiabilitiesNoncurrent 260,264,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 185,140,253
9 ResearchAndDevelopmentExpense 30,502,707
10 remainder_Expenses 72,412,259
11 remainder_Revenues 735,123,731
12 remainder_NetIncome -26,411,199
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 383,527,000
1 Liabilities 369,838,000
2 Expenses 288,055,219
3 Revenues 735,123,731
4 StockholdersEquity 13,689,000
5 NetIncome 420,657,313
6 ComprehensiveNetIncome 420,657,313
7 BaseVar 901,477,574
8 EconomicCapitalRatiobeforeLimitedLiability 1.20
9 EconomicCapitalRatio 2.45

Edgar->Model Mapping

Feature Distribution

Change over Time